Area of research
Cancer Research · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Cancer-related molecular mechanisms research, Metabolomics and Mass Spectrometry Studies, and Cancer Genomics and Diagnostics.
Microbiota-induced alteration of kynurenine metabolism in macrophages drives formation of creeping fat in Crohn’s disease
Chemotherapy-induced microbiota exacerbates the toxicity of chemotherapy through the suppression of interleukin-10 from macrophages
Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer
Targeting DNA Repair Response Promotes Immunotherapy in Ovarian Cancer: Rationale and Clinical Application
Identifying Potential Markers for Monitoring Progression to Ovarian Cancer Using Plasma Label-free Proteomics
Therapeutic applications of PARP inhibitors in ovarian cancer
Nanomaterials assisted laser desorption ionization for differential diagnosis of ovarian cancer and benign ovarian tumors
An immunophenotyping of renal clear cell carcinoma with characteristics and a potential therapeutic target for patients insensitive to immune checkpoint blockade
Integrative prognostic subtype discovery in high‐grade serous ovarian cancer
Villainous role of estrogen in macrophage-nerve interaction in endometriosis
Predicting ovarian cancer recurrence by plasma metabolic profiles before and after surgery
Plasma metabolomic profiling distinguishes right-sided from left-sided colon cancer
Selection of small plasma peptides for the auxiliary diagnosis and prognosis of epithelial ovarian cancer by using UPLC/MS‐based nontargeted and targeted analyses
Macrophage and nerve interaction in endometriosis
A Comprehensive Analysis of Metabolomics and Transcriptomics in Cervical Cancer
Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer
Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer
Erratum: Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
Distinct plasma lipids profiles of recurrent ovarian cancer by liquid chromatography-mass spectrometry
Differential plasma lipids profiling and lipid signatures as biomarkers in the early diagnosis of ovarian carcinoma using UPLC-MS